Kayne Anderson Energy Infrastructure Fund Prices Private Placement of $70 Million of Senior Notes

Written by Customer Service on April 27, 2021. Posted in Public Companies.

HOUSTON, April 27, 2021 (GLOBE NEWSWIRE) — Kayne Anderson Energy Infrastructure Fund, Inc. (the “Company”) (NYSE: KYN) announced that it reached a conditional agreement with institutional investors relating to a private placement of $70 million of senior unsecured notes (“Notes”). The private placement is expected to close on or about May 11, 2021. Net proceeds will be used to refinance existing leverage and for general corporate purposes. The table below sets forth the key terms of the Notes to be issued: Series Principal($ in millions) InterestRate Maturity Date Series PP (floating rate) $50 3-month LIBOR + 125 bps 6/19/2026 Series QQ (fixed rate) $20 1.81% 6/19/2025 Closing of this transaction is subject to investor due diligence, legal documentation, and other standard...

Kayne Anderson NextGen Energy & Infrastructure Prices Private Placement of $20 Million of Mandatory Redeemable Preferred Shares

Written by Customer Service on April 27, 2021. Posted in Public Companies.

HOUSTON, April 27, 2021 (GLOBE NEWSWIRE) — Kayne Anderson NextGen Energy & Infrastructure, Inc. (the “Fund”) (NYSE: KMF) announced that it reached a conditional agreement with institutional investors relating to a private placement of $20 million of mandatory redeemable preferred shares (“MRP Shares”). The private placement is expected to close on or about May 11, 2021. Net proceeds will be used to refinance existing leverage and for general corporate purposes. The table below sets forth the key terms of the floating rate MRP Shares to be issued: Series Liquidation Value($ in millions) DividendRate MandatoryRedemption Date Series I $20 3-month LIBOR + 175 bps 6/1/2026 Closing of this transaction is subject to investor due diligence, legal documentation, and other standard closing conditions....

Provident Financial Holdings Announces Extension of April 2020 Stock Repurchase Plan

Written by Customer Service on April 27, 2021. Posted in Public Companies.

RIVERSIDE, Calif., April 27, 2021 (GLOBE NEWSWIRE) — Provident Financial Holdings, Inc. (“Company”), NASDAQ GS: PROV, the holding company for Provident Savings Bank, F.S.B., today announced that the Company’s Board of Directors authorized an extension of the April 2020 Stock Repurchase Plan (“Plan”) for a period of one year or until completed, whichever occurs first. There are 317,108 shares currently available to be purchased under the Plan. The Corporation will purchase the shares from time to time in the open market or through privately negotiated transactions depending on market conditions, the capital requirements of the Corporation, and available cash that can be allocated to the stock repurchase program, among other considerations. Safe-Harbor Statement Certain matters in this News Release may constitute forward-looking statements...

US FDA Advisory Committee votes in favour of maintaining accelerated approval of Roche’s Tecentriq for PD-L1-positive, metastatic triple-negative breast cancer

Written by Customer Service on April 27, 2021. Posted in Public Companies.

Basel, 28 April 2021 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the US Food and Drug Administration (FDA) Oncologic Drugs Advisory Committee (ODAC) voted 7 to 2 in favour of maintaining accelerated approval of Tecentriq® (atezolizumab) in combination with chemotherapy (Abraxane®, albumin-bound paclitaxel; nab-paclitaxel) for the treatment of adults with unresectable locally advanced or metastatic triple-negative breast cancer (mTNBC) whose tumours express PD-L1, as determined by an FDA-approved test. Today’s ODAC meeting is part of an industry-wide review of accelerated approvals with confirmatory trials that have not met their primary endpoint(s) and have yet to gain regular approvals. The advisory committee provides the FDA with independent opinions and recommendations from outside medical experts, though the recommendations...

Ultragenyx Announces Upcoming Data Presentations at American Society of Gene & Cell Therapy 2021 Virtual Annual Meeting

Written by Customer Service on April 27, 2021. Posted in Public Companies.

NOVATO, Calif., April 27, 2021 (GLOBE NEWSWIRE) — Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultra-rare diseases, today announced that clinical, preclinical and manufacturing data from its investigational gene therapy programs will be presented at the American Society of Gene & Cell Therapy (ASGCT) 24th Annual Meeting, which will be held virtually May 11-14, 2021. “We continue to advance our proprietary HeLa producer cell line (PCL) manufacturing platform and look forward to sharing recent HeLa 3.0 improvements that further increase productivity and reproducibility of this platform, and continue to drive down AAV production costs,” said Sam Wadsworth, Ph.D., Chief Scientific Officer of Ultragenyx Gene Therapy. “We...

Onex Prices U.S. CLO-21

Written by Customer Service on April 27, 2021. Posted in Public Companies.

All amounts in U.S. dollars unless otherwise stated TORONTO, April 27, 2021 (GLOBE NEWSWIRE) — Onex Corporation (“Onex”) (TSX: ONEX) announced that Onex Credit Partners, LLC (“Onex Credit”) priced its 21st U.S. collateralized loan obligation (“CLO”) for approximately $510 million. The transaction will be issued by a special purpose vehicle, backed by a diversified portfolio of broadly syndicated leveraged loans. The CLO is expected to close in early June. U.S. CLO-21 will be managed by the Onex Credit team led by Ronnie Jaber and Karen Lau. The transaction will be supported by a diverse, global group of more than ten investors, including an equity investor who has invested in several Onex Credit CLOs, resulting in approximately two thirds of the CLO equity being taken by third-party investors. This is the firm’s 25th CLO since...

Fourth Consecutive Quarter of Record Net Interest Income

Written by Customer Service on April 27, 2021. Posted in Public Companies.

UNIONDALE, N.Y., April 27, 2021 (GLOBE NEWSWIRE) — Flushing Financial Corporation (the “Company”) (NASDAQ-GS: FFIC) John R. Buran, President and CEO Commentary “We are optimistic that as more people receive vaccines, local economic activity will improve. Our first quarter 2021 actions largely focused on helping our customers navigate an improving, but still challenging environment. Despite these challenges, we achieved our fourth consecutive quarter of record net interest income. We reduced loans in forbearance by 81% from their peak nearly a year ago, and while our forbearance programs will continue into 2022, borrowers’ fundamentals are improving. The recent steepening of the yield curve is a positive for us and we expect to capitalize on our robust loan pipeline. We continue to make investments in our technology platform and...

Suncor Energy to release first quarter 2021 financial results, and hold Annual Meeting of shareholders and Investor Day

Written by Customer Service on April 27, 2021. Posted in Public Companies.

CALGARY, Alberta, April 27, 2021 (GLOBE NEWSWIRE) — Suncor will release its first quarter financial results on May 3, 2020 before 8:00 p.m. MT (10:00 p.m. ET). A webcast to review the first quarter will be held on May 4 at 7:30 a.m. MT (9:30 a.m. ET). Representing management will be Mark Little, president and chief executive officer and Alister Cowan, chief financial officer. A question and answer period with analysts will follow brief remarks from management. Trevor Bell, vice president, Investor Relations will host the call. Please note, telephone lines are limited and reserved for those who intend to ask a question. To participate in the teleconference: if calling from North America: 1-866-219-5885 if calling from outside North America: +1-209-905-5918 To participate in the conference via webcast or to view the archive, go...

Suncor Énergie publiera les résultats financiers du premier trimestre de 2021 et tiendra son assemblée annuelle des actionnaires ainsi qu’une Journée des investisseurs

Written by Customer Service on April 27, 2021. Posted in Public Companies.

CALGARY, Alberta, 27 avr. 2021 (GLOBE NEWSWIRE) — Suncor publiera ses résultats du premier trimestre le 3 mai 2021 avant 20 h, HR (22 h, HE). Une webdiffusion permettant d’analyser les résultats du premier trimestre se tiendra le 4 mai 2021 à 7 h 30, HR (9 h 30, HE). Mark Little, président et chef de la direction, et Alister Cowan, chef des Finances, représenteront la direction. Une période de questions avec les analystes suivra les brèves remarques de la direction. Trevor Bell, vice-président, Relations avec les investisseurs, agira comme animateur. Veuillez noter que le nombre de lignes téléphoniques est limité et que celles-ci sont réservées aux personnes qui désirent poser des questions. Pour participer à la conférence téléphonique : si vous appelez de l’Amérique du Nord, composez le 1-866-219-5885 si vous appelez de...

Supernus to Host First Quarter 2021 Financial Results Conference Call

Written by Customer Service on April 27, 2021. Posted in Public Companies.

ROCKVILLE, Md., April 27, 2021 (GLOBE NEWSWIRE) — Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, today announced that the Company expects to report business results for the first quarter of 2021 after the market closes on Wednesday, May 5, 2021. Jack Khattar, President and CEO, and Jim Kelly, Executive Vice President and CFO, will host a conference call to present the first quarter 2021 financial and business results on Wednesday, May 5, 2021 at 4:30 p.m. ET. Following management’s prepared remarks and discussion of business results, the call will be open for questions. A live webcast will be available at www.supernus.com. Please refer to the information below for conference call dial-in information....

Day: April 27, 2021

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice